Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.
To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.
Please help improve GET-Evidence by evaluating evidence for this variant!
You are viewing an old version of this page that was saved on May 17, 2010 at 11:05pm by PharmGKB Importing Robot.
Added in this revision:
Insufficiently evaluated pharmacogenetic
(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)
Summary of published research, and additional commentary
Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, Silva W Jr, Vilela
G, Zanette DL, Ferry C, Larghero J, Devergie A, Ribaud P, Skvortsova Y, Tamouza
R, Gluckman E, Socie G, Zago MA. Association of drug metabolism gene
polymorphisms with toxicities, graft-versus-host disease and survival after
HLA-identical sibling hematopoietic stem cell transplantation for patients with
leukemia. Leukemia. 2009 Mar;23(3):545-56. Epub 2008 Nov 13. PubMed PMID:
huE80E3D - CGI sample GS00253-DNA_D01_200_37
het T @ chr19:41512841